Transformative New Operating Model to Feature Two Complementary Business Segments Aligned to Customer Needs: Laboratory Solutions and Bioscience Production Company Launches Cost Optimization Initiative to Deliver $300M in Run Rate Savings by the end of 2026 Reaffirms Fiscal Year 2023…